HUP0203050A2 - Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények - Google Patents

Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények

Info

Publication number
HUP0203050A2
HUP0203050A2 HU0203050A HUP0203050A HUP0203050A2 HU P0203050 A2 HUP0203050 A2 HU P0203050A2 HU 0203050 A HU0203050 A HU 0203050A HU P0203050 A HUP0203050 A HU P0203050A HU P0203050 A2 HUP0203050 A2 HU P0203050A2
Authority
HU
Hungary
Prior art keywords
infertility
endometriosis
fertility
treating endometriosis
treatment
Prior art date
Application number
HU0203050A
Other languages
English (en)
Inventor
William J. Bologna
Howard L. Levine
Dominique Ziegler
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of HUP0203050A2 publication Critical patent/HUP0203050A2/hu
Publication of HUP0203050A3 publication Critical patent/HUP0203050A3/hu
Publication of HU225990B1 publication Critical patent/HU225990B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány endometriózis és meddőség kezelésére, valamint atermékenység fokozására alkalmas gyógyszerkészítményekre vonatkozik. Atalálmány szerinti gyógyszerkészítmények (i) gyógyászati szempontbólhatásos mennyiségben az endometriózis vagy a meddőség kezelésére,illetve a termékenység fokozására alkalmas b-adrenerg-agonistavegyületet, továbbá (ii) farmakológiai szempontból elfogadhatóbioadhéziós hordozóanyagot tartalmaznak. A találmány szerintigyógyszerkészítményt a hüvely nyálkahártyáján alkalmazva gyógykezelnilehet az endometriózist és a meddőséget, illetve fokozni lehet atermékenységet. Ó
HU0203050A 1999-10-05 2000-10-04 Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility HU225990B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (3)

Publication Number Publication Date
HUP0203050A2 true HUP0203050A2 (hu) 2003-02-28
HUP0203050A3 HUP0203050A3 (en) 2006-02-28
HU225990B1 HU225990B1 (en) 2008-02-28

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203050A HU225990B1 (en) 1999-10-05 2000-10-04 Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility

Country Status (28)

Country Link
EP (1) EP1220667B1 (hu)
JP (2) JP2003510354A (hu)
KR (1) KR100738724B1 (hu)
CN (1) CN1218694C (hu)
AR (1) AR028487A1 (hu)
AT (1) ATE271860T1 (hu)
AU (1) AU780736B2 (hu)
BR (1) BR0014548A (hu)
CA (1) CA2385974C (hu)
CO (1) CO5251423A1 (hu)
DE (1) DE60012554T2 (hu)
DK (1) DK1220667T3 (hu)
ES (1) ES2223581T3 (hu)
GE (1) GEP20043313B (hu)
HK (1) HK1044120B (hu)
HU (1) HU225990B1 (hu)
IL (2) IL148784A0 (hu)
MA (1) MA25501A1 (hu)
MX (1) MXPA02003453A (hu)
MY (1) MY129518A (hu)
NO (1) NO329663B1 (hu)
NZ (1) NZ518429A (hu)
PE (1) PE20010742A1 (hu)
PT (1) PT1220667E (hu)
TR (1) TR200200899T2 (hu)
TW (1) TWI280877B (hu)
UA (1) UA74168C2 (hu)
WO (1) WO2001024788A2 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
SG10201504913UA (en) * 2010-03-22 2015-07-30 Repros Therapeutics Inc Compositions and methods for non-toxic delivery of antiprogestins
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
IN2014DN10548A (hu) 2012-05-31 2015-08-21 Repros Therapeutics Inc
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
AU5068090A (en) * 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
IL148784A (en) 2006-12-31
DE60012554D1 (de) 2004-09-02
PE20010742A1 (es) 2001-07-19
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
HK1044120A1 (en) 2002-10-11
CO5251423A1 (es) 2003-02-28
MY129518A (en) 2007-04-30
NO20021591L (no) 2002-05-28
HUP0203050A3 (en) 2006-02-28
MA25501A1 (fr) 2002-07-01
KR100738724B1 (ko) 2007-07-12
ATE271860T1 (de) 2004-08-15
NZ518429A (en) 2004-02-27
PT1220667E (pt) 2004-11-30
DK1220667T3 (da) 2004-12-06
NO329663B1 (no) 2010-11-29
NO20021591D0 (no) 2002-04-04
EP1220667B1 (en) 2004-07-28
KR20020062285A (ko) 2002-07-25
CA2385974C (en) 2010-01-26
AR028487A1 (es) 2003-05-14
HU225990B1 (en) 2008-02-28
WO2001024788A3 (en) 2001-12-06
EP1220667A2 (en) 2002-07-10
MXPA02003453A (es) 2002-08-20
CN1377264A (zh) 2002-10-30
CA2385974A1 (en) 2001-04-12
BR0014548A (pt) 2002-06-04
GEP20043313B (en) 2004-03-10
ES2223581T3 (es) 2005-03-01
JP2003510354A (ja) 2003-03-18
HK1044120B (zh) 2004-12-17
TR200200899T2 (tr) 2002-07-22
AU780736B2 (en) 2005-04-14
IL148784A0 (en) 2002-09-12
WO2001024788A2 (en) 2001-04-12
DE60012554T2 (de) 2005-11-24
UA74168C2 (uk) 2005-11-15
CN1218694C (zh) 2005-09-14
TWI280877B (en) 2007-05-11

Similar Documents

Publication Publication Date Title
HUP0101543A2 (hu) Női szexuális zavarok kezelésére szolgáló gyógyszerkészítmények
ATE247950T1 (de) Fentanylzusammensetzung zur behandlung von akutem schmerz
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE245650T1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
RS20120201A2 (en) METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C
CA2339221A1 (en) Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
PT1200412E (pt) Agentes anti-proliferativos de imidazole
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
MY135683A (en) Compositions for improving fertility
HUP0103078A2 (hu) Készítmények és eljárások szürkehályog kezelésére
BR0212787A (pt) Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica
HUP0101546A2 (hu) Opioid antagonistát és NMDA-receptor komplex modulátort tartalmazó gyógyászati készítmény alkohol- és drogfüggőség kezelésére
EA200000355A2 (ru) Промышленные изделия
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
ATE457177T1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
SE9603725D0 (sv) New teatment
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
CA2296560A1 (en) Amino acid derivatives useful to treat stroke